These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8795583)

  • 1. Analysis of IL-2 receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancer.
    Meazza R; Marciano S; Sforzini S; Orengo AM; Coppolecchia M; Musiani P; Ardizzoni A; Santi L; Azzarone B; Ferrini S
    Br J Cancer; 1996 Sep; 74(5):788-95. PubMed ID: 8795583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice.
    Di Carlo E; Meazza R; Basso S; Rosso O; Comes A; Gaggero A; Musiani P; Santi L; Ferrini S
    J Pathol; 2000 Jun; 191(2):193-201. PubMed ID: 10861581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement.
    Di Carlo E; Comes A; Basso S; De Ambrosis A; Meazza R; Musiani P; Moelling K; Albini A; Ferrini S
    J Immunol; 2000 Sep; 165(6):3111-8. PubMed ID: 10975824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 gene.
    Corrias MV; Basso S; Meazza R; Musiani P; Santi L; Bocca P; Occhino M; Ferrini S; Pistoia V
    Cancer Gene Ther; 1998; 5(1):38-44. PubMed ID: 9476965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice.
    Orengo AM; Di Carlo E; Comes A; Fabbi M; Piazza T; Cilli M; Musiani P; Ferrini S
    J Immunol; 2003 Jul; 171(2):569-75. PubMed ID: 12847220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth.
    Lin WC; Yasumura S; Suminami Y; Sung MW; Nagashima S; Stanson J; Whiteside TL
    J Immunol; 1995 Nov; 155(10):4805-16. PubMed ID: 7594483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.
    Hathorn RW; Tso CL; Kaboo R; Pang S; Figlin R; Sawyers C; deKernion JB; Belldegrun A
    Cancer; 1994 Oct; 74(7):1904-11. PubMed ID: 7521786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
    Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
    Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells.
    Carbotti G; Nikpoor AR; Vacca P; Gangemi R; Giordano C; Campelli F; Ferrini S; Fabbi M
    J Exp Clin Cancer Res; 2017 Oct; 36(1):140. PubMed ID: 29020964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of IL-2, IL-4 and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorder.
    Wasik MA; Seldin DC; Butmarc JR; Gertz R; Marti R; Maslinski W; Kadin ME
    Leuk Lymphoma; 1996 Sep; 23(1-2):125-36. PubMed ID: 9021695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human melanoma cells express a functional interleukin-2 receptor.
    Plaisance S; Rubinstein E; Alileche A; Han DS; Sahraoui Y; Mingari MC; Bellomo R; Rimoldi D; Colombo MP; Jasmin C
    Int J Cancer; 1993 Aug; 55(1):164-70. PubMed ID: 8344747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
    Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
    J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells.
    Nakarai T; Robertson MJ; Streuli M; Wu Z; Ciardelli TL; Smith KA; Ritz J
    J Exp Med; 1994 Jul; 180(1):241-51. PubMed ID: 8006584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
    Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence.
    Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M
    Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells.
    Leclercq G; Debacker V; de Smedt M; Plum J
    J Exp Med; 1996 Aug; 184(2):325-36. PubMed ID: 8760786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of interleukin 2 receptor genes into squamous cell carcinoma. Modification of tumor cell growth.
    Lin WC; Yasumura S; Whiteside TL
    Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1229-35. PubMed ID: 8217083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non random activation of endogenous interleukin-2, (IL-2), IL-2 receptor alpha and IL-2 receptor beta genes after transfection of mouse fibroblasts with a cDNA for the alpha chain of the human IL-2 receptor.
    Han D; Plaisance S; Rubinstein E; Alileche A; Pottin-Clemenceau C; Kim TS; Cohen EP; Jasmin C; Azzarone B
    Eur J Immunol; 1995 Jul; 25(7):1905-12. PubMed ID: 7621867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.